Leuprolide Recruiting Phase 2 Trials for Prostate Neoplasms / Prostatic Neoplasms / Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03007732Pembrolizumab in Combination With Intratumoral SD-101 Therapy
NCT03572387A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment
NCT03809000A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
NCT04249154Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
NCT02770391ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer
NCT03899077Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP